ArticleSignal transduction and targeted therapy2025

In vivo self-assembled nano-PROTAC for the dual degradation of AR and HSP90 to overcome castration-resistant prostate cancer resistance.

Fei-Ya Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.